Cardiac Profiles Announces Collaboration with Mayo Clinic to Develop Next Generation Clinical Grade, Consumer Accessible Cardiovascular Monitoring Technology
Mobile monitor to enable new era in Hospital-to-Home management of heart failure
FRANKLIN, Tennessee, February 21, 2019 — Cardiac Profiles, Inc., developer of the FloWave®, a mobile hemodynamic diagnostic and monitoring technology, today announced a collaboration with Mayo Clinic to develop diagnostic and clinical decision support protocols leveraging the FloWave®’s unique hemodynamic cardiac profile to enable hospital-to-home management of heart failure. The FloWave® has been demonstrated to assess concurrent measures of cardiac preload, contractility and afterload, with specific measures of stroke volume, cardiac output and ejection fraction. These metrics have the potential to reduce hospitalizations for heart failure and improve quality of life.
Several companies are now marketing simple single lead ECG devices as standalone products or integrated in smart watches. The introduction of these consumer accessible, clinical grade devices is accelerating the pace of innovation toward a new paradigm in early detection and improved management of cardiovascular disease in the home. However, the single lead ECG does not assess hemodynamic status—the principle measure of cardiovascular health and performance. “The FloWave® represents the next generation of mobile cardiovascular monitoring, equipping patients and their doctors with diagnostic and trending data previously unavailable outside of the hospital or clinic,” said Kin Clinton, CEO of Cardiac Profiles. “If we are to realize meaningful reductions in heart failure related hospitalizations, we must deploy technologies that provide a far more nuanced and clinically actionable picture of patients’ cardiovascular function. And those technologies must be simple, affordable and connected. We are delighted to collaborate with the team at Mayo Clinic to expand the diagnostic reach of the FloWave® and develop the clinical decision support protocols that will finally bend the curve in favor of admission reduction and improved quality of life for those diagnosed with compromised cardiac function,” said Mr. Clinton.
About Cardiac Profiles, Inc.
Cardiac Profiles, Inc. is a privately-held company headquartered in Franklin, Tennessee. For more information, please visit www.cardiacprofiles.com.
FloWave® is a registered trademark of Cardiac Profiles, Inc.
For more information on partnership inquiries, please contact the following: